Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
David A. Rodman, MD
Chief Medical Officer
Mineralys Therapeutics, Inc.
Poster(s):
038: Lorundrostat Concentration-QTc Results from the First-in-Human Study in Healthy Participants Demonstrate Lack of Relevant Effect & Replaces the Thorough QT Study
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
